The implantation of a left ventricular assist device (LVAD) is an important therapeutic tool for patients with end-stage heart failure, which can either help patients transition to the heart transplantation stage or serve as destination therapy until the end of their lives. In recent years, the third generation of LVADs has evolved rapidly and several brands have been marketed both domestically and internationally. The number of LVAD implantations has been increasing and the long-term survival rate of implanted patients has been improving, so this device has a broad development perspective. This paper summarizes the current status of the development of LVAD and its problems, and is expected to be helpful to researchers who are approaching the field for the first time.